Germline Testing in Patients with Breast Canc...

Drs. Zeina Nahleh and Maryam Lustberg join the podcast to discuss the updated ASCO guideline on breast cancer follow-up and surveillance after primary treatment. Drs. Nahleh and Lustberg explain the new risk-stratified approach, which personalizes surveillance intensity based on ...  Show more

Drs. Jamie Lesnock and Sara Bouberhan join the podcast to discuss the first ASCO guideline on systemic treatment for recurrent ovarian cancer. They provide a comprehensive overview of the evidence-based recommendations for patients with both platinum-sensitive and platinum-resist ...  Show more

Join Drs Kevin Kalinsky and Jennifer Litton as they discuss hereditary breast cancer, genetic testing, and therapeutic implications. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarticle/991258). The topics and discussions ...  Show more

<span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Drs. Hope Rugo and Sara Tolaney discuss the promise of antibody-drug conjugates (ADCs) in the treatment of breast cancer, highlighting key trials that shed light on matching the right ADC to the right p ...

In this episode, Dr Parveen Boora discusses breast cancer. Topics covered include: approach to the history and physical exam of breast masses indications for breast imaging and biopsy staging invasive cancer management of breast cancer surgery for primary tumors surgery for axill ...  Show more

This 45-minute podcast features the expertise of a pathologist and an oncologist highlighting important and practice-changing developments related to the use of Ki67 biomarker testing in patients with HR-positive/HER2-negative early breast cancer, such as new clinical data wit ...